中国·澳门沙金(娱乐VIP首页)官方网站-Play Game Store

: R&D Platform

: Pipelines

News

2024/06/13
Hopstem Biotechnology at 2024 CASSS CGPT Symposium
2024/05/17
Hopstem to Showcase hNPC01 Clinical Data at 2024 ASGCT Annual Meeting in Baltimore
2024/03/29
hNPC01, human iPSC-derived human forebrain neural progenitor cell product of Hopstem Biotech has been granted clinical approval treating hemiplegia sequelae after chronic ischemic stroke by FDA
2023/06/21
hNPC01, human iPSC-derived human forebrain neural progenitor cell product of Hopstem Biotech has been granted clinical approval treating hemiplegia sequelae after chronic ischemic stroke by CFDA

Join the leader of iPSC Cell Therapy！

More

Tel：0571-88197776 Email：info@hopstem.com

R&D Center: Building 11,Heda Medicine Valley V, Qiantang Area,
Hangzhou, Zhejiang, China

Manufacturing Center: 3rd & 4th Floor, Building 10,Heda Medicine Valley lll,
Qiantang Area, Hangzhou, Zhejiang, China

U.S. Office: 103 Carnegie center, Suite 300, Princeton,
NJ 08540, USA